| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 28-Nov-08 | | Total Revenue | 8,489,000 | 15,189,000 | 11,880,000 | 3,682,000 | | Cost of Revenue | (1,110,000) | 439,000 | 671,000 | 1,512,000 | | | Gross Profit | 9,599,000 | 14,750,000 | 11,209,000 | 2,170,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| 96,000 | | Selling General and Administrative | 8,321,000 | 7,867,000 | 5,576,000 | (75,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 367,000 | 426,000 | 549,000 | 488,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 911,000 | 6,457,000 | 5,084,000 | 1,661,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,104,000 | 6,457,000 | 5,084,000 | 1,661,000 | | Interest Expense | 1,310,000 | 1,428,000 | 2,455,000 | 5,260,000 | | Income Before Tax | 4,794,000 | 5,029,000 | 2,629,000 | (3,599,000) | | Income Tax Expense | 1,606,000 | 1,594,000 | 815,000 | (1,478,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,188,000 | 3,435,000 | 1,814,000 | (2,121,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,188,000 | 3,435,000 | 1,814,000 | (2,121,000) | | Preferred Stock And Other Adjustments | (160,000) | (717,000) | (155,000) | (166,000) | | | Net Income Applicable To Common Shares | $3,028,000 | $2,718,000 | $1,659,000 | ($2,287,000) |
|
0.01% Nasdaq 
0.22%
Income Statement
